Omics biomarkers for frailty in older adults
Y Pan, T Ji, Y Li, L Ma - Clinica Chimica Acta, 2020 - Elsevier
Frailty is a clinical state characterized by an age-related unsteady state of the body, a
decline in physiological function, and an increased vulnerability to adverse outcomes. Early …
decline in physiological function, and an increased vulnerability to adverse outcomes. Early …
Omics biomarkers for frailty in older adults.
Y Pan, T Ji, Y Li, L Ma - Clinica Chimica Acta; International Journal …, 2020 - europepmc.org
Frailty is a clinical state characterized by an age-related unsteady state of the body, a
decline in physiological function, and an increased vulnerability to adverse outcomes. Early …
decline in physiological function, and an increased vulnerability to adverse outcomes. Early …
Omics biomarkers for frailty in older adults.
Y Pan, T Ji, Y Li, L Ma - 2020 - cabidigitallibrary.org
Frailty is a clinical state characterized by an age-related unsteady state of the body, a
decline in physiological function, and an increased vulnerability to adverse outcomes. Early …
decline in physiological function, and an increased vulnerability to adverse outcomes. Early …
Omics biomarkers for frailty in older adults
Y Pan, T Ji, Y Li, L Ma - Clinica chimica acta; international …, 2020 - pubmed.ncbi.nlm.nih.gov
Frailty is a clinical state characterized by an age-related unsteady state of the body, a
decline in physiological function, and an increased vulnerability to adverse outcomes. Early …
decline in physiological function, and an increased vulnerability to adverse outcomes. Early …